Home » News » August 2022

August, 2022

Academics call for R&D Tax Incentives to be Diverted to Direct Funding Initiatives, Swanson Reed Disagrees

August 31st, 2022

In an article published in the AFR on 30 April, Deputy vice-chancellor of research at the University of Sydney Emma Johnston called on the government to fund research and innovation directly (e.g. via a grant), rather than through tax incentives. It was noted as being part of a push for greater mobility between the corporate and business sectors, which leading academics say will boost investment in research and innovation. Professor Johnston was quoted in AFR stating that the R&D tax […]

Read More

InnovationAus Analysis of Public Funding for R&D in USA Compared with Australia

August 29th, 2022

A recent article by Dr John Howard on InnovationAus has highlighted a comparison between Public Funding for R&D in USA (following passage of a new act) against Australia. The article highlights that: The Chips for America Fund (US$52.7 billion) and recently enacted CHIPS and Science Act will authorise a five-year US$169.9 billion (A$245 billion) Research and Innovation Initiative – a US$82.5 billion increase over the current baseline. This is the biggest five-year investment in public R&D in United States history. […]

Read More

New Industry and Science Minister Ed Husic Meets with Tech Sector Leaders Ahead of September Jobs and Skills Summit

August 22nd, 2022

StartupDaily has reported that over the past week, the new Minister for Industry and Science, Ed Husic, has held discussions with industry leaders covering themes including: Science and commercialisation (August 17) Digital and tech skills (August 17) Advanced manufacturing (August 18) Artificial intelligence (August 19). The discussions come ahead of the new Government’s planned Jobs and Skills Summit to be held by stakeholders in September. Before the election, the new Industry Minister made some encouraging comments about the R&D Tax […]

Read More

Telix Pharmaceuticals becomes Australian Biotech Success Story after being one of largest Refundable R&D Tax Offset Recipients

August 15th, 2022

Melbourne-based Telix Pharmaceuticals has been one of the largest recipients of the R&D Tax incentive, and has now achieved a rare feat in Biotechnology;  commercialising a product, and continuing to grow. The company reportedly received a more than $12M R&D tax offset refund for activity undertaken during the year ended 31 December 2020, and more than $11M in the preceding period, for their work on cancer diagnostic and treatment. Telix Pharmaceuticals’ technology uses radio pharmaceuticals to travel through the blood […]

Read More

Categories

Archives